SHINYA YAMAMOTO to Neoplasms
This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Neoplasms.
Connection Strength
0.406
-
Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases. Adv Exp Med Biol. 2018; 1066:141-185.
Score: 0.187
-
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study. Cancer Chemother Pharmacol. 2025 Mar 21; 95(1):46.
Score: 0.077
-
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study. Int J Clin Oncol. 2024 Apr; 29(4):398-406.
Score: 0.071
-
Introduction to Notch signaling. Methods Mol Biol. 2014; 1187:1-14.
Score: 0.035
-
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer Chemother Pharmacol. 2024 10; 94(4):615-622.
Score: 0.018
-
Rare de novo gain-of-function missense variants in DOT1L are associated with developmental delay and congenital anomalies. Am J Hum Genet. 2023 11 02; 110(11):1919-1937.
Score: 0.017